复方萘酚喹及其组分单药治疗恶性疟的临床研究

目的对比观察复方萘酚喹(Co-NQ)与组分单药萘酚喹(NQ)和青蒿素(QHS)对恶性疟的疗效和安全性。方法用Co-NQ(总量含NQ400mg及QHS1000mg)、NQ(总量1000mg)和QHS(总量2500mg)分别治疗恶性疟患者100例、100例和30例。所有患者住院7d,随访28d,观察疗效和安全性。结果Co-NQ、NQ和QHS3组的平均退热时间分别为(17.5±12.3)h,(32.7±17.7)h和(18.1±9.7)h;平均原虫转阴时间分别为(30.0±8.8)h,(45.5±10.0)h和(29.1±6.0)h;28d治愈率分别为97.0％,100.0％和66.7％。Co-NQ组临床未见不良反应。结论Co-NQ具有QHS的速效和NQ的持效作用,是一个高效、速效、持效的新复方。

Efficacy of Naphthoquine, Artemisinine and a Combination of the Two Drugs in the Treatment of Falciparum Malaria

OBJECTIVE: To compare the efficacy and safety of naphthoquine, artemisinine and a combination of the two drugs in the treatment of faciparum malaria. METHODS: Of 230 patients, 100 patients were treated with combined regime (Co-NQ), 100 patients were treated with naphthoquine (NQ) and 30 patients were treated with artemisinine (QHS). All patients were hospitalized for 7 days and followed up for 28 days. RESULTS: The mean fever clearance time for Co-NQ, NQ, and QHS was (17.5 +/- 12.3)h, (32.7 +/- 17.7)h and (18.1 +/- 9.7)h respectively; the mean parasite clearance time was (30.0 +/- 8.8)h, (45.5 +/- 10.0)h and (29.1 +/- 6.0)h respectively; and the 28 days cure rate was 97.0%, 100.0% and 66.7% respectively. CONCLUSION: The Co-NQ possesses benefits of both naphthoquine and artemisinine, acting rapidly, with a short course of only one dose and a high cure rate. The regime is well tolerated by patients.